Blackstone’s life sciences-focused real estate unit plans to purchase a 2.3 million square foot portfolio of lab office buildings from Brookfield Asset Management’s real estate fund for $3.45 billion.
The transaction is slated to close next quarter and represents a sizable move into the Boston/Cambridge market that will make Blackstone the largest life science office owner in the area.
Blackstone Property Partners Life Sciences is a distinct segment of Blackstone’s existing $174 billion real estate business in that it is a long-term, perpetual capital vehicle that is . . .
Unlock this article instantly, along with the rest of our premium content, newsletters and data tables tracking investor and manager activity. Annual subscriptions get you the most bang for your buck, including access to Alternatives Watch Research articles and out Annual Investor Compendium.
Monthly subscriptions and discounted corporate plans for up to 100 members also available.